Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 85.60
0.00 (0.00%)
Oct 21, 2026, 5:24 PM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 6.52 million as of October 23, 2026. It is the 47,839th most valuable company in the world and the 490th biggest in Israel. Its market cap has increased by 20.75% in one year.
Market Cap
6.52M
Enterprise Value
-1.68M
Revenue
-1.24M
Global Rank
Country Rank
#490 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 6.52M, a decrease of -83.82%. That is a compound annual growth rate of -26.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.52M | 32.64% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.67B |
| Amal Holdings A.D. | 2.16B |
| Rafa Laboratories | 1.77B |
| BrainsWay | 1.48B |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.55M |
| Evogene | 18.42M |
| PsyRX CNS Bio-Tech | 8.70M |